6-118558626-TACACACACACACACACACAC-TACACACACACACACACACACACACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_001042475.3(CEP85L):c.1020+6895_1020+6902dupGTGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.048 ( 127 hom., cov: 0)
Consequence
CEP85L
NM_001042475.3 intron
NM_001042475.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.379
Publications
0 publications found
Genes affected
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
PLN (HGNC:9080): (phospholamban) The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]
PLN Gene-Disease associations (from GenCC):
- dilated cardiomyopathy 1PInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- intrinsic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 18Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
new If you want to explore the variant's impact on the transcript NM_001042475.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 6-118558626-T-TACACACAC is Benign according to our data. Variant chr6-118558626-T-TACACACAC is described in ClinVar as Benign. ClinVar VariationId is 1236113.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0717 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001042475.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEP85L | MANE Select | c.1020+6895_1020+6902dupGTGTGTGT | intron | N/A | NP_001035940.1 | Q5SZL2-1 | |||
| PLN | MANE Select | c.-97-171_-97-164dupCACACACA | intron | N/A | NP_002658.1 | P26678 | |||
| CEP85L | c.1029+6895_1029+6902dupGTGTGTGT | intron | N/A | NP_001171506.1 | Q5SZL2-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CEP85L | TSL:1 MANE Select | c.1020+6902_1020+6903insGTGTGTGT | intron | N/A | ENSP00000357477.3 | Q5SZL2-1 | |||
| PLN | TSL:1 MANE Select | c.-97-199_-97-198insACACACAC | intron | N/A | ENSP00000350132.5 | P26678 | |||
| CEP85L | TSL:1 | c.1029+6902_1029+6903insGTGTGTGT | intron | N/A | ENSP00000392131.1 | A2A3P3 |
Frequencies
GnomAD3 genomes AF: 0.0479 AC: 5330AN: 111182Hom.: 128 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
5330
AN:
111182
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0479 AC: 5327AN: 111244Hom.: 127 Cov.: 0 AF XY: 0.0463 AC XY: 2412AN XY: 52058 show subpopulations
GnomAD4 genome
AF:
AC:
5327
AN:
111244
Hom.:
Cov.:
0
AF XY:
AC XY:
2412
AN XY:
52058
show subpopulations
African (AFR)
AF:
AC:
996
AN:
30752
American (AMR)
AF:
AC:
386
AN:
11116
Ashkenazi Jewish (ASJ)
AF:
AC:
210
AN:
2860
East Asian (EAS)
AF:
AC:
120
AN:
3984
South Asian (SAS)
AF:
AC:
210
AN:
2606
European-Finnish (FIN)
AF:
AC:
126
AN:
4764
Middle Eastern (MID)
AF:
AC:
16
AN:
208
European-Non Finnish (NFE)
AF:
AC:
3132
AN:
52726
Other (OTH)
AF:
AC:
85
AN:
1490
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
199
397
596
794
993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.